Literature DB >> 8372197

Neuroimaging of juvenile pilocytic astrocytomas: an enigma.

M J Fulham1, J W Melisi, J Nishimiya, A J Dwyer, G Di Chiro.   

Abstract

PURPOSE: To present the imaging, metabolic, and clinical data obtained in five patients with juvenile pilocytic astrocytomas (JPAs) and discuss the paradoxical neuroimaging findings.
MATERIALS AND METHODS: Five patients with JPAs who had undergone structural imaging and fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) were studied. Normalized glucose utilization rates (GURs) in the tumor were compared with GURs in histopathologically verified low-grade astrocytomas and high-grade tumors.
RESULTS: All JPAs enhanced markedly after administration of contrast medium. Their glucose metabolism was significantly (P < .001) higher than that of low-grade astrocytomas and was similar to that of anaplastic astrocytomas. All patients with JPAs were in stable condition and showed no evidence of disease progression despite contrast enhancement and high tumoral glucose metabolism.
CONCLUSION: The paradoxical FDG PET findings and enhancement at structural imaging might reflect the unusual vascularity of pilocytic tumors, and the increased GUR might be related to expression of the glucose transporter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8372197     DOI: 10.1148/radiology.189.1.8372197

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  Utility of positron emission tomography for tumour surveillance in children with neurofibromatosis type 1.

Authors:  Mahendranath Moharir; Kevin London; Robert Howman-Giles; Kathryn North
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-24       Impact factor: 9.236

Review 2.  Intra-axial brain tumours.

Authors:  G Wilms; Ph Demaerel; S Sunaert
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

Review 3.  Advances in the assessment of childhood brain tumors and treatment-related sequelae.

Authors:  Katherine E Warren
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 4.  Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

Authors:  P Rigo; P Paulus; B J Kaschten; R Hustinx; T Bury; G Jerusalem; T Benoit; J Foidart-Willems
Journal:  Eur J Nucl Med       Date:  1996-12

Review 5.  Prediction of brain tumor therapy response by PET.

Authors:  R G Blasberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI.

Authors:  Sean J Hipp; Emilie A Steffen-Smith; Nicholas Patronas; Peter Herscovitch; Jeffrey M Solomon; Robyn S Bent; Seth M Steinberg; Katherine E Warren
Journal:  J Neurooncol       Date:  2012-07-04       Impact factor: 4.130

7.  A case of Lhermitte-Duclos disease presenting high FDG uptake on FDG-PET/CT.

Authors:  Toshio Nakagawa; Masayuki Maeda; Mikiyoshi Kato; Naohiro Terada; Shigetoshi Shimizu; Yoshito Morooka; Hiroshi Nakano; Kan Takeda
Journal:  J Neurooncol       Date:  2007-02-27       Impact factor: 4.130

Review 8.  PET and SPECT studies in children with hemispheric low-grade gliomas.

Authors:  Csaba Juhász; Edit Bosnyák
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

9.  Perfusion-sensitive MRI of pilocytic astrocytomas: initial results.

Authors:  Sylvie D Grand; Stéphane Kremer; Irène M Tropres; Dominique M Hoffmann; Stephan J Chabardes; Virginie Lefournier; François R Berger; Caroline Pasteris; Alexandre Krainik; Basile M Pasquier; Michel Peoch; Jean François Le Bas
Journal:  Neuroradiology       Date:  2007-05-26       Impact factor: 2.804

10.  Usefulness of perfusion- and diffusion-weighted imaging to differentiate between pilocytic astrocytomas and high-grade gliomas: a multicenter study in Japan.

Authors:  Kazufumi Kikuchi; Akio Hiwatashi; Osamu Togao; Koji Yamashita; Ryotaro Kamei; Mika Kitajima; Masafumi Kanoto; Hiroto Takahashi; Yusuke Uchiyama; Masafumi Harada; Yuki Shinohara; Takashi Yoshiura; Yuki Wakata; Hiroshi Honda
Journal:  Neuroradiology       Date:  2018-02-15       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.